Weekly company factor report
ANCR
Animalcare Group plc
Current comparison
Latest company comparison
The scores rank this company against other measured companies in the selected market. Open each section to check the figures behind them.
Strong price performance, high variability
Price performance ranks 88/100, but one-year volatility is 42%. The price path has been less stable than the headline return.
Four main ranks
Company profile
Completed weekly snapshots
How the ranks have changed
Ready-made approaches
Which screens include this company
Passing a screen means the latest completed snapshot meets that screen’s published rules. It is not a recommendation.
Continue the research
Check the supporting evidence
Open the price record, technical position, market group or other company research that is available for ANCR.
Price against company results
Value
A higher value rank means the shares are cheaper on the combined definitions relative to this market. Negative earnings or cash flow need separate attention.
Current reading
The P/E ratio is 45.6 times earnings, which is high on the page’s valuation scale. The six-measure value score is 97.00000000/100, indicating a high valuation across the combined measures; lower is cheaper.
Value measures compared
Raw multiples and yields
P/E history
P/E is shown only when trailing earnings are positive.
Research path
How to test this valuation
A low valuation is a starting point. These checks show whether the earnings base, cash flow and completed price record support it.
Profitability, cash and balance sheet
Financial strength
The rank combines several company measures. The chart and figures below keep profitability, leverage and cash conversion visible separately.
Financial measures compared
Profitability and leverage
Completed returns and variability
Price performance and risk
Returns show direction; volatility and drawdown show how uneven the path has been. Both are based on completed prices.
Current reading
The 12-month return excluding the latest month is 24%. Near-term vol (104%) is expanding vs long-term (42%) — risk is increasing.
Returns over several periods
Recent and one-year volatility
How long the current readings have persisted
| Measure | Current | Current run | Direction |
|---|---|---|---|
| OS Composite | 0.170 | Unchanged for 4 snapshots | stable |
| Value %ile | 0.040 | Unchanged for 10 snapshots | deteriorating |
| Quality %ile | 0.160 | Unchanged for 4 snapshots | deteriorating |
| Momentum %ile | 0.880 | Unchanged for 5 snapshots | improving |
| F-Score | 6.000 | Unchanged for 0 snapshots | stable |
| Confidence | 0.724 | Unchanged for 10 snapshots | deteriorating |
| Volatility | 0.423 | Unchanged for 10 snapshots | deteriorating |
Like-for-like context
Sector comparison
The company is compared with measured companies in Healthcare for the same completed factor week.
Company against sector
Valuation distance from sector
| Company | Combined | Value | Financial strength | Price performance |
|---|---|---|---|---|
| AGY Allergy Therapeutics plc | 94.0 | 79.0 | 80.0 | 81.0 |
| FAB Fusion Antibodies plc | 93.0 | 78.0 | 79.0 | 79.0 |
| FUM Futura Medical plc | 93.0 | 78.0 | 79.0 | 80.0 |
| PXS Provexis plc | 92.0 | 77.0 | 78.0 | 78.0 |
| GDR genedrive plc | 90.0 | 75.0 | 77.0 | 77.0 |
| AOTI AOTI, Inc. | 88.0 | 74.0 | 75.0 | 76.0 |
| ABDX Abingdon Health Plc | 88.0 | 74.0 | 75.0 | 75.0 |
| APTA Aptamer Group PLC | 86.0 | 72.0 | 73.0 | 74.0 |
Reported company accounts
Company figures
Quarterly and annual figures are kept separate. The dates below show the latest accepted reporting periods.
Annual figures
Revenue
Net income
Free cash flow
Net margin
Operating income
Operating cash flow
Capital expenditure
Equity and liabilities
Definitions and source checks
Measures and data
Each figure is shown with its plain definition. Percentile ranks compare the company with the selected market for the same completed week.